LHC Group (NASDAQ:LHCG) Lowered to “Buy” at BidaskClub

BidaskClub lowered shares of LHC Group (NASDAQ:LHCG) from a strong-buy rating to a buy rating in a research report sent to investors on Tuesday, BidAskClub reports.

Other equities research analysts also recently issued reports about the company. Deutsche Bank initiated coverage on LHC Group in a research report on Monday, September 16th. They issued a buy rating and a $145.00 target price for the company. Oppenheimer upped their target price on LHC Group from $125.00 to $146.00 and gave the stock an outperform rating in a research report on Friday, August 9th. Royal Bank of Canada set a $135.00 target price on LHC Group and gave the stock a buy rating in a research report on Friday, August 9th. Barclays increased their price objective on LHC Group from $113.00 to $120.00 and gave the company an equal weight rating in a research report on Friday, August 9th. Finally, Zacks Investment Research upgraded LHC Group from a hold rating to a buy rating and set a $130.00 price objective for the company in a research report on Thursday, June 27th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. LHC Group has a consensus rating of Buy and a consensus price target of $129.70.

LHCG opened at $117.65 on Tuesday. The company has a market capitalization of $3.73 billion, a price-to-earnings ratio of 33.14, a price-to-earnings-growth ratio of 1.96 and a beta of 0.85. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.59 and a quick ratio of 1.59. LHC Group has a 1-year low of $80.84 and a 1-year high of $129.37. The business has a 50 day moving average price of $120.21 and a two-hundred day moving average price of $115.82.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, August 7th. The health services provider reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. The firm had revenue of $517.84 million during the quarter, compared to the consensus estimate of $524.24 million. LHC Group had a return on equity of 8.83% and a net margin of 4.20%. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.84 earnings per share. Equities analysts expect that LHC Group will post 4.34 EPS for the current fiscal year.

Several large investors have recently made changes to their positions in LHCG. Geode Capital Management LLC lifted its position in shares of LHC Group by 6.7% during the 4th quarter. Geode Capital Management LLC now owns 325,548 shares of the health services provider’s stock valued at $30,562,000 after acquiring an additional 20,482 shares during the last quarter. Janus Henderson Group PLC lifted its position in shares of LHC Group by 21.9% during the 1st quarter. Janus Henderson Group PLC now owns 5,308 shares of the health services provider’s stock valued at $588,000 after acquiring an additional 955 shares during the last quarter. Mason Street Advisors LLC lifted its position in shares of LHC Group by 3.5% during the 1st quarter. Mason Street Advisors LLC now owns 9,380 shares of the health services provider’s stock valued at $1,040,000 after acquiring an additional 319 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in shares of LHC Group by 1.8% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 11,301 shares of the health services provider’s stock valued at $1,253,000 after acquiring an additional 204 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of LHC Group by 108.3% during the 1st quarter. JPMorgan Chase & Co. now owns 62,305 shares of the health services provider’s stock valued at $6,907,000 after acquiring an additional 32,400 shares during the last quarter. Institutional investors own 90.15% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Read More: What is a closed-end mutual fund (CEF)?

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.